肥胖治疗

肥胖治疗概念板块聚焦代谢干预与体重管理。核心赛道涵盖GLP‑1/GIP等新型减重药物、减重手术/介入与器械、数字疗法及营养管理。板块总市值达 46432.69 billion KRW,24h 涨跌幅 -2.71%,24 个标的中上涨 5 个(占比 20.83%),下跌 19 个(占比 79.17%)。领涨个股为 光东制药 (009290),24h 涨幅 +1.43%。肥胖治疗板块趋软,板块广度疲弱且领涨股集中。短期内在回调时偏好优质龙头;中期在出现临床/监管催化剂和业绩明朗时增持,同时控制波动性。
名称
最新价
涨跌幅
最新价 / 涨跌幅
走势图
价格区间
操作
051910
LG化学051910
⁦K227,000.00⁩$169.96
-2.15%-$3.74
⁦K227,000.00⁩
-2.15%
$168.46$171.08
128940
韩美制药128940
⁦K446,500.00⁩$334.30
-4.08%-$14.23
⁦K446,500.00⁩
-4.08%
$332.43$345.16
000100
柳韩洋行000100
⁦K81,100.00⁩$60.72
+1.24%+$0.75
⁦K81,100.00⁩
+1.24%
$59.52$60.72
347850
D&D Pharmatech347850
⁦K38,000.00⁩$28.45
-6.63%-$2.02
⁦K38,000.00⁩
-6.63%
$28.45$30.21
000250
三泉堂制药000250
⁦K165,900.00⁩$124.21
-7.31%-$9.81
⁦K165,900.00⁩
-7.31%
$124.21$129.98
226950
奥利克斯制药226950
⁦K75,000.00⁩$56.15
-7.29%-$4.42
⁦K75,000.00⁩
-7.29%
$56.15$59.67
087010
佩普特朗087010
⁦K88,500.00⁩$66.26
-4.53%-$3.14
⁦K88,500.00⁩
-4.53%
$65.81$69.41
456160
G2G Bio456160
⁦K32,900.00⁩$24.63
-5.73%-$1.50
⁦K32,900.00⁩
-5.73%
$24.63$25.68
068760
赛尔群制药068760
⁦K40,400.00⁩$30.25
-1.70%-$0.52
⁦K40,400.00⁩
-1.70%
$30.25$31.00
195940
HK inno.N195940
⁦K36,150.00⁩$27.07
+0.55%+$0.15
⁦K36,150.00⁩
+0.55%
$26.77$27.37
069620
大熊制药069620
⁦K100,700.00⁩$75.40
-1.17%-$0.90
⁦K100,700.00⁩
-1.17%
$74.35$75.85
047920
HLB Pharma047920
⁦K6,800.00⁩$5.09
-4.36%-$0.23
⁦K6,800.00⁩
-4.36%
$5.09$5.34
214370
Caregen214370
⁦K27,900.00⁩$20.89
-0.88%-$0.19
⁦K27,900.00⁩
-0.88%
$20.89$21.71
009290
光东制药009290
⁦K6,360.00⁩$4.76
+1.43%+$0.07
⁦K6,360.00⁩
+1.43%
$4.66$4.78
389470
Inventage Lab389470
⁦K18,930.00⁩$14.17
-6.28%-$0.95
⁦K18,930.00⁩
-6.28%
$14.05$14.95
185750
Chong Kun Dang185750
⁦K61,400.00⁩$45.97
+0.16%+$0.07
⁦K61,400.00⁩
+0.16%
$45.52$46.12
048870
协同创新048870
⁦K1,267.00⁩$0.95
-5.02%-$0.05
⁦K1,267.00⁩
-5.02%
$0.94$0.99
256840
韩国BNC256840
⁦K2,155.00⁩$1.61
-2.48%-$0.04
⁦K2,155.00⁩
-2.48%
$1.59$1.65
249420
日东制药249420
⁦K12,270.00⁩$9.19
-2.38%-$0.22
⁦K12,270.00⁩
-2.38%
$9.18$9.40
003220
大元制药003220
⁦K7,790.00⁩$5.83
-0.25%-$0.01
⁦K7,790.00⁩
-0.25%
$5.77$5.87